Pharma Goes Cloud Gazing (Analyst Opinion)

Introduction

The current life sciences R&D model is evolving to incorporate biotechnology and bioinformatics. With IT infrastructures already operating at full capacity, several Big Pharma and Big Biotech companies are adopting the cloud to increase their computing power and enable innovative research.

Scope

*Discusses the use of cloud computing within the life sciences industry

*Analyzes the impact of the cloud on data processing and data storage

*Examines the pros and cons of leveraging cloud computing for pharma

Highlights

In-house IT infrastructures are operating at full load, leaving little room for researchers to run innovative experiments that require high computing power or for companies to store massive amounts of data on their servers. Rather than go the route of adding more hardware, IT directors have sought out cloud computing services.

Security is a big concern for an industry that relies solely on intellectual property and patent.

A lack of standards on using data processed in the cloud could potentially cause problems with regulatory agencies since it may be difficult to safeguard the data and prevent tampering.

Reasons to Purchase

*Learn how the life sciences industry is leveraging the cloud

*Understand what pharma companies are looking for from a cloud computing platform


Report Highlights

[Studien Infos ausblenden]

DATAMONITOR OPINION 1
Catalyst 1
Summary 1
Comment 2
Ask the analyst 4
Disclaimer 4

[Inhaltsverzeichnis ausblenden]